The Center for Biomedical Research Transparency (CBMRT) hosts a free 5-year Biomedical Transparency Summit (BMTS) series in the US and Europe. The goal of BMTS is to promote discussion and collaboration on transparency across the global biomedical research ecosystem
Linking Evidence to Aid researchers in tackling the 2019 novel coronavirus outbreak
As the collection of literature and resources on the 2019 novel coronavirus outbreak increases, Evidence Aid is working to ensure links to the latest research are made discoverable
Guest post: Some of the open science challenges faced by authors in Japan
Scientific and medical publishing is becoming more open around the world, including in Japan, where open access and open science are gaining traction.
What does the future look like for medical publications? Insights from ISMPP EU 2020
The 2020 European Meeting of the International Society for Medical Publication Professionals (ISMPP) opened with a question – in one word, “how do you feel about the future of medical publications?” Answers included “exciting”, “evolving” and “digital”.
Guest post: ORCID adoption in the pharma community
ORCID is part of the wider digital infrastructure needed for researchers to share information on a global scale. ORCID enables transparent and trustworthy connections between researchers, their contributions, and affiliations by providing an identifier for individuals to use with their name as they engage in research, scholarship and innovation activities. The Open Pharma community is … Continue reading Guest post: ORCID adoption in the pharma community
Open Pharma top holiday reads
Finding a good book to read on holiday may sometimes be a challenge. Luckily, the Open Pharma team is here to help with its shortlist of the best reads for summer 2019!
Open science is essential for medical research, says ABPI
The Association of the British Pharmaceutical Industry (ABPI) has said that it wants to take transparency to the next level, and has committed to making clinical research more accessible and understandable across the pharmaceutical industry.
Resolving conflicts of interest in medicine
At a workshop on managing conflicts of interest in medicine, Chris Winchester, CEO of Oxford PharmaGenesis and co-founder of Open Pharma, argued for openness.
Clinical trial transparency – time for pharma to go above and beyond?
On 11–12 June 2019, over 60 pharma stakeholders met in Amsterdam at the
8th Annual Publication and Clinical Trial Transparency Conference to discuss the evolving landscape of clinical trial transparency.
GPCAP recommendations strengthen the credibility of medical conference presentations
The Good Practice for Conference Abstracts and Presentations (GPCAP) recommendations have been developed to address the challenges faced by industry professionals and authors when preparing abstracts and presentations for academic conferences.